Mednax Inc. Hits New 52-Week High at $56.52 (MD)
Shares of Mednax (NYSE:MD) hit a new 52-week high during trading on Monday , AmericanBankingNews.com reports. The stock traded as high as $56.52 and last traded at $56.32, with a volume of 559,812 shares trading hands. The stock had previously closed at $55.30.
Separately, analysts at KeyCorp initiated coverage on shares of Mednax in a research note to investors on Tuesday, December 17th. They set a “hold” rating on the stock. Eight research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $106.57.
The stock’s 50-day moving average is $53.92 and its 200-day moving average is $52.24. The company has a market cap of $5.691 billion and a price-to-earnings ratio of 19.91.
Mednax (NYSE:MD) last posted its quarterly earnings results on Thursday, January 30th. The company reported $0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.75 by $0.55. The company had revenue of $567.00 million for the quarter, compared to the consensus estimate of $555.30 million. Analysts expect that Mednax will post $3.15 EPS for the current fiscal year.
MEDNAX, Inc (NYSE:MD) is a provider of physician services, including newborn, maternal-fetal, pediatric subspecialties and anesthesia care.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.